A Phase II Study of the c-Met Inhibitor Tivantinib in Combination with FOLFOX for the Treatment of Patients with Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction, or Stomach
暂无分享,去创建一个
J. Bendell | C. Kurkjian | S. Pant | B. Hemphill | M. Flores | M. Patel | Dana S. Thompson